Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-001474
Filing Date
2025-03-05
Accepted
2025-03-05 13:29:04
Documents
36
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q fussbrands_10q.htm   iXBRL 10-Q 432233
2 EXHIBIT 31.1 fussbrands_ex31-1.htm EX-31.1 14757
3 EXHIBIT 32.1 fussbrands_ex32-1.htm EX-32.1 5564
  Complete submission text file 0001829126-25-001474.txt   2170773

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fbds-20250131.xsd EX-101.SCH 14967
5 XBRL CALCULATION FILE fbds-20250131_cal.xml EX-101.CAL 22119
6 XBRL DEFINITION FILE fbds-20250131_def.xml EX-101.DEF 46906
7 XBRL LABEL FILE fbds-20250131_lab.xml EX-101.LAB 183526
8 XBRL PRESENTATION FILE fbds-20250131_pre.xml EX-101.PRE 148054
38 EXTRACTED XBRL INSTANCE DOCUMENT fussbrands_10q_htm.xml XML 173569
Mailing Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004
Business Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004 917-720-3366
Fuss Brands Corp. (Filer) CIK: 0000926844 (see all company filings)

EIN.: 841273503 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-34808 | Film No.: 25709924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)